학술논문
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
Document Type
Article
Author
Machiels, Jean-Pascal H; Haddad, Robert I; Fayette, Jérôme; Licitra, Lisa F; Tahara, Makoto; Vermorken, Jan B; Clement, Paul M; Gauler, Thomas; Cupissol, Didier; Grau, Juan José; Guigay, Joël; Caponigro, Francesco; de Castro, Gilberto, Jr; de Souza Viana, Luciano; Keilholz, Ulrich; del Campo, Joseph M; Cong, Xiuyu Julie; Ehrnrooth, Eva; Cohen, Ezra E W
Source
In The Lancet Oncology May 2015 16(5):583-594
Subject
Language
ISSN
1470-2045